IP Verse

Develco Pharma Schweiz competitive analysis

Loading summary...

Latest oppositions filed by Develco Pharma Schweiz

Explore patent oppositions filed by Develco Pharma Schweiz against competitors, revealing strategic technology disputes and market positioning.

Last updated on: Oct 23, 2025

Patent Number	Title	Applicant	Opposition Date
Get instant updates on new opposition filings by the company
EP3578173	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Oct 26, 2022
EP3024461	A Combination Of Oxycodone And Naloxone For Use In Treating Pain In Patients Suffering From Pain And A Disease Resulting In Intestinal Dysbiosis And/Or Increasing The Risk For Intestinal Bacterial Translocation	EURO CELTIQUE	May 14, 2020
EP2962686	Dosage Form Containing Oxycodone And Naloxone	EURO CELTIQUE	Apr 11, 2019
EP2425821	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	May 11, 2017
EP2425824	Pharmaceutical Preparation Containing Oxycodone And Naloxone	EURO CELTIQUE	May 11, 2017

Latest publications and patents of Develco Pharma Schweiz New

Explore the latest publications and patents granted to Develco Pharma Schweiz, showcasing their recent innovations and technological advancements.

Latest PTAB cases involving Develco Pharma Schweiz

Discover the latest PTAB cases involving Develco Pharma Schweiz, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Develco Pharma Schweiz with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025

Company	Oppositions Filed	Oppositions Faced	PTAB Cases Filed	PTAB Cases Faced
DEVELCO PHARMA SCHWEIZ	5	-	-	-
EURO CELTIQUE	-	44	-	-
MUNDIPHARMA	-	25	-	-
NAPP PHARMACEUTICAL	-	25	-	-